JP2023546453A5 - - Google Patents
Info
- Publication number
- JP2023546453A5 JP2023546453A5 JP2023524276A JP2023524276A JP2023546453A5 JP 2023546453 A5 JP2023546453 A5 JP 2023546453A5 JP 2023524276 A JP2023524276 A JP 2023524276A JP 2023524276 A JP2023524276 A JP 2023524276A JP 2023546453 A5 JP2023546453 A5 JP 2023546453A5
- Authority
- JP
- Japan
- Prior art keywords
- substituted
- pharmaceutically acceptable
- solvate
- acceptable salt
- compound according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063094793P | 2020-10-21 | 2020-10-21 | |
| US63/094,793 | 2020-10-21 | ||
| US202163170988P | 2021-04-05 | 2021-04-05 | |
| US63/170,988 | 2021-04-05 | ||
| PCT/IB2021/000707 WO2022084738A2 (en) | 2020-10-21 | 2021-10-20 | Compounds and methods for the treatment of ocular disorders |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023546453A JP2023546453A (ja) | 2023-11-02 |
| JP2023546453A5 true JP2023546453A5 (https=) | 2024-10-29 |
Family
ID=81291739
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023524276A Pending JP2023546453A (ja) | 2020-10-21 | 2021-10-20 | 眼障害を処置するための化合物および方法 |
Country Status (8)
| Country | Link |
|---|---|
| EP (1) | EP4232149A4 (https=) |
| JP (1) | JP2023546453A (https=) |
| KR (1) | KR20230110515A (https=) |
| AU (1) | AU2021363702A1 (https=) |
| CA (1) | CA3196145A1 (https=) |
| IL (1) | IL302173A (https=) |
| MX (1) | MX2023004537A (https=) |
| WO (1) | WO2022084738A2 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP7700045B2 (ja) | 2019-04-18 | 2025-06-30 | アズーラ オフサルミックス エルティーディー． | 眼障害を処置するための化合物および方法 |
| US11459351B1 (en) | 2021-04-05 | 2022-10-04 | Azura Ophthalmics Ltd. | Compounds and methods for the treatment of ocular disorders |
| WO2024100454A2 (en) * | 2022-11-11 | 2024-05-16 | Azura Ophthalmics Ltd. | Composition and methods for improving signs and symptoms of ocular disorders |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1483579A4 (en) * | 2002-02-15 | 2006-07-12 | Merckle Gmbh | CONJUGATES OF BIOLOGICALLY ACTIVE COMPOUNDS, PROCESS FOR THEIR MANUFACTURE AND USE, FORMULATION AND PHARMACEUTICAL APPLICATIONS THEREOF |
| CA2840626A1 (en) * | 2011-06-29 | 2013-01-03 | Insite Vision Incorporated | Methods of treating recurrent meibomian glands disorder and thereby decreasing the frequency of recurrence |
| WO2018161039A1 (en) * | 2017-03-03 | 2018-09-07 | Synovo Gmbh | Novel anti-infective and anti-inflammatory compounds |
| WO2018215638A1 (en) * | 2017-05-26 | 2018-11-29 | Novaliq Gmbh | Pharmaceutical compositions comprising azithromycin |
| EP3955937A4 (en) * | 2019-04-18 | 2023-01-18 | Azura Ophthalmics Ltd. | COMPOUNDS AND COMPOSITIONS FOR THE TREATMENT OF EYE DISEASES |
-
2021
- 2021-10-20 IL IL302173A patent/IL302173A/en unknown
- 2021-10-20 WO PCT/IB2021/000707 patent/WO2022084738A2/en not_active Ceased
- 2021-10-20 JP JP2023524276A patent/JP2023546453A/ja active Pending
- 2021-10-20 AU AU2021363702A patent/AU2021363702A1/en not_active Abandoned
- 2021-10-20 CA CA3196145A patent/CA3196145A1/en active Pending
- 2021-10-20 KR KR1020237016470A patent/KR20230110515A/ko active Pending
- 2021-10-20 EP EP21882226.0A patent/EP4232149A4/en active Pending
- 2021-10-20 MX MX2023004537A patent/MX2023004537A/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023546453A5 (https=) | ||
| CA2504846A1 (en) | Antiviral nucleoside derivatives | |
| DE69814012D1 (de) | Hypoglykàmische imidazoline derivate | |
| RU2006137706A (ru) | 9-замещенное производное 8-оксоаденина | |
| AR041272A1 (es) | Compuestos de pirazol como inhibidores del factor de crecimiento transformante (tgf) y composicion farmaceutica que los contiene | |
| HUE048936T2 (hu) | Glikopirrolátot és egy béta2 adrenoreceptor agonistát tartalmazó gyógyszerkészítmény | |
| JP2023546915A5 (https=) | ||
| JP6847170B2 (ja) | ジアミン架橋剤、酸性多糖架橋体、及び医用材料 | |
| KR910007908A (ko) | 신규 화합물들 | |
| RU2013156939A (ru) | Способ лечения лихорадки денге | |
| JP2025506206A (ja) | がん治療のためのチオストレプトンから着想された化合物及びその調製 | |
| JP2023546452A5 (https=) | ||
| CA2491612A1 (en) | 4-'7-halo-2-quino(xa-)linyloxy!phenoxy-propionic acid derivatives as antineoplastic agents | |
| EP0463514B1 (en) | 3.3'-Dithiobis (propionic acids) and esters thereof | |
| JP2003511412A5 (https=) | ||
| RU2014132830A (ru) | Конъюгаты антагонистов интегрина для нацеленной доставки к клеткам, экспрессирующим vla-4 | |
| RU2008112181A (ru) | Применение конденсированных производных имидазола для лечения заболеваний, опосредованных рецептором ccr3 | |
| RU2005130992A (ru) | Производные сложноэфирных липидов нуклеотидов | |
| RU2012138955A (ru) | Циклопентилпроизводные диазенийдиолата | |
| RU2004111789A (ru) | Ретиноидные агонисты | |
| JP2010513262A5 (https=) | ||
| US5889050A (en) | 3,3'-dithiobis (propionic acids) and esters thereof | |
| EP2527352A3 (en) | Caprazene derivatives | |
| US20110218237A1 (en) | Compound and composition and their uses thereof | |
| RU2004113208A (ru) | Получение ингибиторов протеазы вич |